Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With Type 2 Diabetes
Reason given: Lack of participants eligible for study
Key facts
- Where
- Rockport, United StatesSee the site
Where in United States
- PenBay Medical CenterRockport, United StatesNo longer taking part
Trial details
- Who runs it
- Tracy Jalbuena MD
- Trial code
- NCT05541120
- Record updated
- 16 February 2023
- Original description
This is a randomized controlled trial of the use of Remote Patient Monitoring (RPM) compared to usual care among rural patients with poorly controlled type 2 diabetes. Usual care is defined as participation in Living Well with Diabetes/Virtual Diabetes Self-Management Program and Primary Care Provider evaluation and management at the providers' discretion, including medication adjustment or interventions, and other types of interventions depending on clinical judgement.Read full original descriptionShow less
This is a randomized controlled trial of the use of Remote Patient Monitoring (RPM) compared to usual care among rural patients with poorly controlled type 2 diabetes. Usual care is defined as participation in Living Well with Diabetes/Virtual Diabetes Self-Management Program and Primary Care Provider evaluation and management at the providers' discretion, including medication adjustment or interventions, and other types of interventions depending on clinical judgement.
Inclusion: Be enrolled in Living Well with Diabetes education program; Have an HbA1c% ≥ 8 in the prior 6 months; Be capable of providing consent; Be adults (age 18 or over).
Exclusion: Primarily managed by endocrinology for their diabetes (> 1 visit with endocrinology in the previous 12 months); Have previously participated in the Living Well with Diabetes/Virtual Diabetes Self-Management Program; Have previously used a remote patient monitoring device for diabetes management; Diagnosed with type 1 diabetes; Have a diagnosis of dementia or other clinical diagnosis that would impair participation capacity; Currently participating in any other clinical trial regarding diabetes care or management; Candidate for continuous glucose monitoring, as defined by Centers for Medicare and Medicaid Services as using at least three insulin injections per day, any combination of types of insulins; Incarcerated; PCP not at one of the 30 primary care practices listed (see attachment List of PCP Practices); Pregnant; Currently enrolled in hospice; Currently residing in a long term care or rehabilitation facility.